CARDIOVASCULAR EVENTS WITH DE NOVO USE OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS

被引:0
|
作者
Potena, Luciano [1 ]
Schulz, Uwe
Bara, Christoph [2 ]
Arizon Del Prado, Jose M. [3 ]
Balfour, Alison [4 ]
Kohler, Sven [4 ]
Lopez, Patricia M. [4 ]
Epailly, Eric [5 ]
机构
[1] Univ Bologna, Acad Hosp S Orsola Malpighi, Bologna, Italy
[2] Hannover Med Sch, Hannover, Germany
[3] HURS, Cordoba, Spain
[4] Novartis Pharma AG, Basel, Switzerland
[5] Chirurg Cardiaque Hop Univ Strasbourg, Strasbourg, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:46 / 46
页数:1
相关论文
共 50 条
  • [41] PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPPRESSIVE THERAPY FOR DE NOVO KIDNEY TRANSPLANT RECIPIENTS IN RUSSIA
    Avxentyev, N. A.
    Derkach, E., V
    Prokopenko, E., I
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2019, 21 (01): : 23 - 34
  • [42] Influence of everolimus on cyclosporine neoral pharmacokinetics in Chinese de novo cardiac transplant recipients
    Wang, C. -H.
    Chou, N. -K.
    Wu, F-L. L.
    Ko, W. -J.
    Tsao, C. -I.
    Chi, N. -H.
    Hsu, R. -B.
    Wang, S. -S.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2032 - 2034
  • [43] EARLY WITHDRAWAL OF CALCINEURIN INHIBITORS AND EVEROLIMUS MONOTHERAPY IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Montalti, Roberto
    Rompianesi, Gianluca
    Masetti, Michele
    Di Benedetto, Fabrizio
    Cautero, Nicola
    De Ruvo, Nicola
    Guerrini, Gian Piero
    Ballarin, Roberto
    Smerieri, Nazareno
    Gerunda, Giorgio E.
    LIVER TRANSPLANTATION, 2009, 15 (07) : S96 - S97
  • [44] Pharmacokinetics of Everolimus When Combined With Cyclosporine in Japanese De Novo Renal Transplant Recipients
    Uchida, K.
    Hoshinaga, K.
    Watarai, Y.
    Goto, N.
    Kusaka, M.
    Sasaki, H.
    Hirano, M.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (05) : 1314 - 1318
  • [45] EVEROLIMUS BASED/CNI FREE REGIMEN IN DE-NOVO RENAL TRANSPLANT RECIPIENTS
    Fior, Francesca
    Nacchia, Francesco
    Ngoufet, Rostand M.
    Rugiu, Carlo
    Ghimenton, Claudio
    Andreotti, Cristina
    Boschiero, Luigi
    TRANSPLANT INTERNATIONAL, 2011, 24 : 180 - 181
  • [46] LONGER-TERM EFFICACY AND SAFETY OF EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Watarai, Yoshihiko
    Uchida, Kazuharu
    Takahara, Shiro
    Yoshimura, Norio
    Teraoka, Satoshi
    Cornu-Artis, Catherine
    Kobayashi, Eiji
    Takahashi, Kota
    TRANSPLANT INTERNATIONAL, 2013, 26 : 81 - 81
  • [47] De novo aortopathy and cardiovascular outcomes in paediatric liver transplant recipients
    Huang, James G.
    Lim, Terence
    Quek, Swee-Chye
    Quak, Seng-Hock
    Aw, Marion M.
    CARDIOLOGY IN THE YOUNG, 2018, 28 (08) : 986 - 994
  • [48] Use of Everolimus in De Novo Renal Recipients: Initial Experience in the Greek Population
    Papanikolaou, V.
    Vrochides, D.
    Margari, P.
    Imvrios, G.
    Papagiannis, A.
    Giakoustidis, D.
    Fouzas, I.
    Antoniadis, N.
    Ouzounidis, N.
    Ntinas, A.
    Vergoulas, G.
    Miserlis, G.
    Solonaki, F.
    Takoudas, D.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 3166 - 3169
  • [49] Everolimus Use in Lung Transplant Recipients
    Turkkan, Sinan
    Basaran, Fatmanur Celik
    Sahin, Mehmet Furkan
    Beyoglu, Muhammet Ali
    Yilmaz, Emre
    Ozay, Hulya Yigit
    Bindal, Mustafa
    Yazicioglu, Alkin
    Yekeler, Erdal
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (08) : 2317 - 2324
  • [50] Sirolimus in de novo heart transplant recipients with severe renal impairment
    de Prada, JAV
    Vilchez, FG
    Cobo, M
    Ruisanchez, C
    Valls, MF
    Ruano, J
    Piñera, C
    Duran, RM
    TRANSPLANT INTERNATIONAL, 2006, 19 (03) : 245 - 248